HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daphne Adele Haas-Kogan Selected Research

pivalyloxymethyl butyrate

4/2007In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas.
12/2005Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daphne Adele Haas-Kogan Research Topics

Disease

3Glioma (Gliomas)
08/2007 - 12/2005
3Neoplasms (Cancer)
07/2007 - 12/2005

Drug/Important Bio-Agent (IBA)

2ProdrugsIBA
08/2007 - 12/2005
2Histone Deacetylase InhibitorsIBA
04/2007 - 12/2005
2Butyrates (Butyrate)IBA
04/2007 - 12/2005
2Histones (Histone)IBA
04/2007 - 12/2005
2Butyric Acid (Butanoic Acid)IBA
04/2007 - 12/2005
2pivalyloxymethyl butyrateIBA
04/2007 - 12/2005
14-phenylbutyric acid (Buphenyl)FDA Link
08/2007
1Pharmaceutical PreparationsIBA
08/2007
1butyroyloxymethyl 4-phenylbutyrateIBA
08/2007
1Phosphatidylinositols (Phosphatidylinositol)IBA
07/2007
1Antineoplastic Agents (Antineoplastics)IBA
12/2005

Therapy/Procedure

2Therapeutics
04/2007 - 12/2005
1Radiotherapy
12/2005